Table 4.

Candidate therapeutic agents against breast cancer.

Rank	CMap name	Mean	N	Enrichment	P	Specificity	Percent non-null
1	Harmalol	−0.82	3	−0.943	0.00028	0	100
2	Flucloxacillin	−0.362	4	−0.808	0.00265	0.0063	50
3	Lasalocid	−0.418	4	−0.807	0.00271	0.037	50
4	Tiletamine	−0.339	4	−0.794	0.00358	0.0057	50
5	Carteolol	−0.26	4	−0.777	0.00511	0.0177	50
6	Ethosuximide	0.371	4	0.767	0.00569	0.0145	50
7	Finasteride	−0.349	6	−0.635	0.00693	0.1402	50
8	Scriptaid	0.507	3	0.818	0.01192	0.1389	66
9	Clemastine	−0.467	3	−0.808	0.01418	0.0504	66
10	Mycophenolic acid	−0.542	3	−0.793	0.01797	0.0974	66
11	Prestwick-857	−0.54	4	−0.696	0.01804	0.0382	75
12	Coralyne	−0.571	4	−0.692	0.0193	0.0067	75
13	Amphotericin B	−0.598	4	−0.687	0.02065	0.0385	75
14	Caffeic acid	0.455	3	0.78	0.02143	0.0208	66
15	Clebopride	−0.582	4	−0.675	0.02487	0.0132	75
16	Nabumetone	0.335	4	0.665	0.02839	0.0325	50
17	Alimemazine	−0.534	4	−0.661	0.0298	0.0272	75
18	(-)-Atenolol	0.376	4	0.658	0.03165	0.0147	50
19	Colecalciferol	0.191	4	0.646	0.03804	0.0469	50
20	Piretanide	−0.392	4	−0.643	0.03909	0.0833	50
21	Zardaverine	0.327	4	0.635	0.04327	0.0725	50
22	Dimenhydrinate	−0.195	4	−0.634	0.04368	0.0432	50
23	Bumetanide	−0.424	4	−0.629	0.04629	0.1622	50